Results 101 to 110 of about 347,568 (271)
A recipe for myositis : nuclear factor κB and nuclear factor of activated T-cells transcription factor pathways spiced up by cytokines [PDF]
Nuclear factor κB (NF-κB) is a well-known pro-inflammatory transcription factor that regulates the expression of the tissue’s immune-active components, which include cytokines, chemokines and adhesion molecules.
De Paepe, Boel
core +3 more sources
ABSTRACT Introduction Percutaneous large‐bore vacuum suction biopsy (LBVSB) is an innovative alternative to open surgical biopsy and minimally invasive image‐guided percutaneous core needle biopsy (PCNB) for pediatric soft tissue tumors. This study reviews our experience using this modality.
Abhinav R. Balu +8 more
wiley +1 more source
[Polymyositis-dermatomyositis recognized during the follow-up of a patient with type 2 diabetes]. [PDF]
Polymyositis-dermatomyositis is a rare systemic autoimmune disease which belongs to the class of idiopathic inflammatory myopathies. The disease exhibits high inter-individual variability, but chronic myositis is a common feature.
Csóka, Mária +2 more
core +2 more sources
Juvenile dermatomyositis (JDM) is an important subtype of dermatomyositis characterized by inflammation of muscle, skin and gastrointestinal tract. A 14-year-old girl, with a history of fever, joint pain, easy fatigability and a rash since the age of 3 years is described.
Sidra, Ishaque +3 more
openaire +3 more sources
ABSTRACT Background Childhood interstitial lung disease (chILD) is rare, heterogeneous, and presents major treatment challenges. This bibliometric study analyzes research trends and hotspots specifically within the domain of chILD treatment research. Methods Using bibliometrics, this study utilized data from the Web of Science Core Collection spanning ...
Lina Ma +3 more
wiley +1 more source
Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis
Juvenile dermatomyositis (JDM) is a systemic vasculopathy with weakness and rash, frequently exhibiting a chronic/polycyclic course, and treated with broad immunosuppression.
Hanna Kim +23 more
semanticscholar +1 more source
Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature [PDF]
Macrophage activation syndrome (MAS) is a potentially fatal condition. It is a rare complication of several autoimmune disorders, including systemic lupus erythematosus (SLE) and systemic juvenile idiopathic arthritis (sJIA).
Didona, Dario +4 more
core +4 more sources
First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis.
B. Palterer, G. Vitiello, D. Cammelli
doaj +1 more source
Patients with anti‐Mi‐2 and anti‐NXP2 antibodies had higher risks of short‐ and long‐term relapse, whether in the Cox model or the competing risk model. ABSTRACT Objectives To explore the clinicopathological features and treatment prognosis including death, relapse and remission of dermatomyositis (DM) based on myositis‐specific autoantibody (MSAs ...
Ying Hou +16 more
wiley +1 more source
Dermatomyositis Associated with Celiac Disease: Response to a Gluten-Free Diet
The association between dermatomyositis and celiac disease in children has been well documented. In the adult population, however, the association has not been clearly established.
Min Soo Song +5 more
doaj +1 more source

